GL1X · GenesisL1 explorer

Research workbench

Cqyn meditope - cetuximab Fab

Analyse Cqyn meditope - cetuximab Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GW5
Type
protein
Length
880 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab light chain; Fab heavy chain; Cqyn meditope
Ligands
PO4
Pockets
11 · best druggability 0.75

Structure

x-ray diffraction · 5 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFab light chainprotein2126% helix, 51% strand—
BFab heavy chainprotein2169% helix, 52% strand—
CFab light chainprotein2136% helix, 51% strand—
DFab heavy chainprotein2157% helix, 52% strand—
E, FCqyn meditopeprotein120% helix, 50% strand—

Ligands and binding sites

  • PO4 · Phosphate ion · ion · 3 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110930.750.78109empty
23930.610.7749empty
33810.610.7744empty
4550.480.8622empty
51410.440.7631empty

Interfaces

7 interfaces between chains.

  • C–D · 1731 Ų buried · 18 hydrogen bonds · protein-protein
  • A–B · 1723 Ų buried · 16 hydrogen bonds · protein-protein
  • A–C · 678 Ų buried · 9 hydrogen bonds · protein-protein
  • B–E · 428 Ų buried · 1 hydrogen bond · protein-protein
  • D–F · 403 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 4GW5 · cQYN meditope - Cetuximab Fab · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.